Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease
Orginal Article |
Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development
Chitra Joseph1, Abubakar Siddiq Mangani1, Veer Gupta2, Nitin Chitranshi1, Ting Shen1, Yogita Dheer1, Devaraj KB1, Mehdi Mirzaei3, Yuyi You1,4, Stuart L. Graham1,4,*, Vivek Gupta1,*
1Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia
2School of Medicine, Deakin University, Melbourne, VIC, Australia.
3Department of Molecular Sciences, Macquarie University, North Ryde, NSW 2109, Australia
4Save Sight Institute, Sydney University, Sydney, NSW 2109, Australia
Download: PDF(709 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  

Cell cycle dysregulation has been implicated in the pathogenesis of neurodegenerative disorders. Specialised function obligates neuronal cells to subsist in a quiescent state of cell cycle once differentiated and therefore the circumstances and mechanisms underlying aberrant cell cycle activation in post-mitotic neurons in physiological and disease conditions remains an intriguing area of research. There is a strict requirement of concurrence to cell cycle regulation for neurons to ensure intracellular biochemical conformity as well as interrelationship with other cells within neural tissues. This review deliberates on various mechanisms underlying cell cycle regulation in neuronal cells and underscores potential implications of their non-compliance in neural pathology. Recent research suggests that successful duplication of genetic material without subsequent induction of mitosis induces inherent molecular flaws that eventually assert as apoptotic changes. The consequences of anomalous cell cycle activation and subsequent apoptosis are demonstrated by the increased presence of molecular stress response and apoptotic markers. This review delineates cell cycle events under normal physiological conditions and deficits amalgamated by alterations in protein levels and signalling pathways associated with cell-division are analysed. Cell cycle regulators essentially, cyclins, CDKs, cip/kip family of inhibitors, caspases, bax and p53 have been identified to be involved in impaired cell cycle regulation and associated with neural pathology. The pharmacological modulators of cell cycle that are shown to impart protection in various animal models of neurological deficits are summarised. Greater understanding of the molecular mechanisms that are indispensable to cell cycle regulation in neurons in health and disease conditions will facilitate targeted drug development for neuroprotection.

Keywords Cell cycle      Apoptosis      Neuron      Neurodegeneration      CDK      Cyclin     
Corresponding Authors: Stuart L. Graham,Vivek Gupta   
About author:

These authors contributed equally to this work.

Just Accepted Date: 22 October 2019  
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Chitra Joseph
Abubakar Siddiq Mangani
Veer Gupta
Nitin Chitranshi
Ting Shen
Yogita Dheer
Devaraj KB
Mehdi Mirzaei
Yuyi You
Stuart L. Graham
Vivek Gupta
Cite this article:   
Chitra Joseph,Abubakar Siddiq Mangani,Veer Gupta, et al. Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development[J]. Aging and disease, 10.14336/AD.2019.0923
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2019.0923     OR     http://www.aginganddisease.org/EN/Y/V/I/0
Figure 1.  Schematic representation elucidating various factors involved in cell cycle activation and apoptosis induction in neurons. Growth factor deprivation (a), neurotoxic accumulation of protein polymers (b), DNA damage (c) and oxidative stress (d) may lead to aberrant cell cycle activation characterised by an increase in cyclin-dependent kinases (CDKs), cyclin, proliferating cell nuclear antigen (PCNA) and a decrease in CDK inhibitors. The synchronised effects of increased cdk4/6, cdk2 and decreased CDK inhibitors p21 and p16 (e) result in retinoblastoma protein (Rb) hyperphosphorylation and release of E2 Transcription Factor (E2F) that initiate transcription of target genes responsible for DNA replication. However, due to lack of mitotic signals (activation of cyclin A and cell division cycle 2 (cdc2)), these actively replicating cells are unable to exit the cell cycle and end up with double the amount of DNA. This leads to p53 induced apoptosis activation, and bax, caspase upregulation that drives the neurons to programmed cell death (PCD).
DiseasesGeneRegionCell cycle phaseRefs
Alzheimer's diseaseCDK1/Cdc2, Cyclin B1Neurons with neurofibrillary tangle s (IHC)G0-G1, G2/M[108]
Cdk5Whole brain lysate (WB)S[109]
p25/CDK5Neuro fibrillary tangle bearing neurons (WB, IHC)G1/S[110]
cyclin B1, cyclin D, CDK4, PCNAHippocampus, subiculum, locus coeruleus, dorsal raphe, inferotemporal cortex, cerebellumG1/S, M[111]
Cyclin D1, cyclin E, Cyclin A pRbCortical neurons exposed to β amyloidG1/S[112]
CDK2, CDK4, CDK6, cyclin B, and cyclin DPeripheral lymphocytes (WB)G1/S, M[113]
CDK4, p16Hippocampus (IHC)G1[114]
P25, p35Frontal cortex, inferior parietal cortex and hippocampus (WB)G1/S[115]
CDC25Aneurofibrillary tangles and senile plaque bearing neurons Hippocampus (WB, IHC)G1/S[116]
Cyclin D, PCNA, Cyclin B1Hippocampus (IHC)G1/S, M[108]
Cdc2/Cyclin B1, CyclinD1, CDK4, pRb
PCNA
Hemibrain homogenatesG1/S, M[117]
Hippocampus (WB, IHC)G1/S
BAXSenile plaques Hippocampus (IHC)[118]
P53superior temporal gyrus (WB)G1[119]
Rbneurofibrillary tangles and senile plaque bearing neurons (IHC) HippocampusG1/S[120]
Glaucoma & other retinal disordersGadd45a and Ei24(p53 family)Retina (qPCR and WB)[121]
Cyclin D1Optic nerve head (ONH) (Microarray)G1[122]
CDKN2A & CDKN2BRetina (RT-PCR)G1[123]
Cyclin B1RPE cells (WB)G2/M[124]
p53, p21RPE cells (WB)G1[125]
p16Primary RPE cells (WB)G1[126]
CDKN1RPE cells (WB)G1[127]
NUCKS1peripheral human retina (PR) and peripheral RPE-Choroid-Scleral (PRCS) tissues (RNA-Seq)M[128]
Cyclin DMacular cells (qRT PCR)G1[129]
BaxRetina (WB & IF)G1[130]
p27Kip1Retina (IHC)G1[131]
p53Retinal pericytes (WB)G1[132]
Amyotrophic lateral sclerosisE2f, cyclin D1, CDK4, pRblumbar spinal cord and pre-/postcentral gyrus (IHC, WB)G1[133]
Bax, caspase 3, caspase 8, p53, ppRblumbar spinal cord (IHC, IF, WB)G1[134]
P53Spinal cord, motor cortex (IHC, WB)G1[135]
CDK5Spinal cord (IHC, WB)G1/S[136]
CDK4, CDK5, CDK6, cyclin D1Spinal cord (IHC)G1[137]
Parkinson's diseaseRbSN nuclei, Frontal cortex and hippocampus (IHC)G1/S[138]
PCNA, E2F,Dopaminergic neurons in SN (IHC, IF)G1/S[139]
PCNA,Dopaminergic neurons in SN(IF)G1/S[140]
cyclin D, cyclin A, cyclin E and cyclin BIF of embryonic rat mid brain neuronsG1/S, G2/M
CDK5, CDK2Dopaminergic neurons in SN (IHC, WB, kinase assay) in MTP treated miceG1/S
p53caudate nucleus (WB) in human PD brainG1[141]
p53Dopaminergic cells (IF, WB) in vitro (6-hydroxydopamine) and mouse model (PQ/MB)
Whole brain lysates (WB) in human PD brains
G1[142, 143]
Table 1  Cell cycle modulatory proteins/genes identified in Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and ophthalmic neurodegenerative disorders such as glaucoma, age related macular degeneration (AMD) and diabetic retinopathies are listed along with the tissues examined.
Figure 2.  Schematic representation of cell cycle in healthy and degenerating neurons. In physiological conditions neural precursor cells go through G1, S, G2 and mitotic phases of cell cycle (inner circle) delivering early progenitor cell that can differentiate to mature neurons (left arrow). However, a mature dormant neuron in G0 phase may re-enter the cell cycle under pathological conditions. This cell then proceeds through all the different phases in interphase but is hindered at the end of G2 (outer circle). Instead of proceeding to mitotic (M) phase these tetraploid cells may undergo apoptosis (right arrow). Pharmacological compounds that affect various cell cycle stages and potentially could be neuroprotective at different stages of the cell cycle are also shown. Cyclin-dependent kinase (CDK5) and cyclin D in G1 phase can be inhibited by CDK5 inhibitory peptide (CIP), indirubin, and flavopiridol respectively. Roscovitine inhibits CDK5 interaction with multiple cyclins involved in G1 and S phase. Olomoucine imparts neuroprotection by regulating CDK5/cyclin interaction throughout interphase. Kenpaullone is a potent cdk1/cyclin B inhibitor effective in G2 phase.
[1] Barnum KJ, O'Connell MJ (2014). Cell cycle regulation by checkpoints. Methods Mol Biol, 1170:29-40.
[2] Satyanarayana A, Kaldis P (2009). Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene, 28:2925-2939.
[3] Massague J (2004). G1 cell-cycle control and cancer. Nature, 432:298-306.
[4] Agarwal ML, Agarwal A, Taylor WR, Stark GR (1995). p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A, 92:8493-8497.
[5] Giono LE, Manfredi JJ (2006). The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol, 209:13-20.
[6] Strausfeld U, Labbe JC, Fesquet D, Cavadore JC, Picard A, Sadhu K, et al. (1991). Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein. Nature, 351:242-245.
[7] Chi H, Chang HY, Sang TK (2018). Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases. Int J Mol Sci, 19.
[8] Rieux-Laucat F, Le Deist F, Hivroz C, Roberts I, Debatin K, Fischer A, et al. (1995). Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science, 268:1347-1349.
[9] Andreau K, Perfettini J-L, Castedo M, Métivier D, Scott V, Pierron G, et al. (2004). Contagious apoptosis facilitated by the HIV-1 envelope: fusion-induced cell-to-cell transmission of a lethal signal. J Cell Sci, 117:5643-5653.
[10] Liao H-S, Kang PM, Nagashima H, Yamasaki N, Usheva A, Ding B, et al. (2001). Cardiac-Specific Overexpression of Cyclin-Dependent Kinase 2 Increases Smaller Mononuclear Cardiomyocytes. Circ Res, 88:443-450.
[11] Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502:333.
[12] Cordon-Cardo C (1995). Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol, 147:545-560.
[13] Bonelli P, Tuccillo FM, Borrelli A, Schiattarella A, Buonaguro FM (2014). CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity. Biomed Res Int, 2014:361020.
[14] Frade JM, Ovejero-Benito MC (2015). Neuronal cell cycle: the neuron itself and its circumstances. Cell Cycle, 14:712-720.
[15] Tomashevski A, Webster DR, Grammas P, Gorospe M, Kruman II (2010). Cyclin-C-dependent cell-cycle entry is required for activation of non-homologous end joining DNA repair in postmitotic neurons. Cell Death Differ, 17:1189.
[16] Park DS, Morris EJ, Padmanabhan J, Shelanski ML, Geller HM, Greene LA (1998). Cyclin-dependent Kinases Participate in Death of Neurons Evoked by DNA-damaging Agents. J Cell Biol, 143:457-467.
[17] Park DS, Levine B, Ferrari G, Greene LA (1997). Cyclin Dependent Kinase Inhibitors and Dominant Negative Cyclin Dependent Kinase 4 and 6 Promote Survival of NGF-Deprived Sympathetic Neurons. J Neurosci, 17:8975-8983.
[18] Park DS, Morris EJ, Bremner R, Keramaris E, Padmanabhan J, Rosenbaum M, et al. (2000). Involvement of Retinoblastoma Family Members and E2F/DP Complexes in the Death of Neurons Evoked by DNA Damage. J Neurosci, 20:3104-3114.
[19] Ajioka I, Martins RAP, Bayazitov IT, Donovan S, Johnson DA, Frase S, et al. (2007). Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell, 131:378-390.
[20] Beijersbergen RL, Carlee L, Kerkhoven RM, Bernards R (1995). Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev, 9:1340-1353.
[21] Marampon F, Casimiro MC, Fu M, Powell MJ, Popov VM, Lindsay J, et al. (2008). Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaB. Mol Biol Cell, 19:2566-2578.
[22] Morillo SM, Escoll P, de la Hera A, Frade JM (2010). Somatic tetraploidy in specific chick retinal ganglion cells induced by nerve growth factor. Proc Natl Acad Sci U S A, 107:109-114.
[23] Rohrer H, Thoenen H (1987). Relationship between differentiation and terminal mitosis: chick sensory and ciliary neurons differentiate after terminal mitosis of precursor cells, whereas sympathetic neurons continue to divide after differentiation. The Journal of Neuroscience, 7:3739-3748.
[24] Kristiansen M, Ham J (2014). Programmed cell death during neuronal development: the sympathetic neuron model. Cell Death Differ, 21:1025-1035.
[25] Park DS, Morris EJ, Greene LA, Geller HM (1997). G1/S Cell Cycle Blockers and Inhibitors of Cyclin-Dependent Kinases Suppress Camptothecin-Induced Neuronal Apoptosis. The Journal of Neuroscience, 17:1256-1270.
[26] Giovanni A, Wirtz-Brugger F, Keramaris E, Slack R, Park DS (1999). Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J Biol Chem, 274:19011-19016.
[27] Migheli A, Piva R, Casolino S, Atzori C, Dlouhy SR, Ghetti B (1999). A Cell Cycle Alteration Precedes Apoptosis of Granule Cell Precursors in the weaver Mouse Cerebellum. The American Journal of Pathology, 155:365-373.
[28] Konishi Y, Lehtinen M, Donovan N, Bonni A (2002). Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol Cell, 9:1005-1016.
[29] Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS (1994). p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci U S A, 91:7525-7529.
[30] Macleod KF, Hu Y, Jacks T (1996). Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. The EMBO Journal, 15:6178-6188.
[31] Kruman II, Wersto RP, Cardozo-Pelaez F, Smilenov L, Chan SL, Chrest FJ, et al. (2004). Cell Cycle Activation Linked to Neuronal Cell Death Initiated by DNA Damage. Neuron, 41:549-561.
[32] Bai G, Pfaff SL (2011). Protease regulation: the Yin and Yang of neural development and disease. Neuron, 72:9-21.
[33] Mirzaei M, Pushpitha K, Deng L, Chitranshi N, Gupta V, Rajput R, et al. (2019). Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease. Mol Neurobiol, 56:6017-6034.
[34] Gupta VK, Gowda LR (2008). Alpha-1-proteinase inhibitor is a heparin binding serpin: molecular interactions with the Lys rich cluster of helix-F domain. Biochimie, 90:749-761.
[35] Nonaka T, Masuda-Suzukake M, Hosokawa M, Shimozawa A, Hirai S, Okado H, et al. (2018). C9ORF72 dipeptide repeat poly-GA inclusions promote: intracellular aggregation of phosphorylated TDP-43. Hum Mol Genet.
[36] Roos RAC (2010). Huntington's disease: a clinical review. Orphanet Journal of Rare Diseases, 5:40.
[37] Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011). Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med, 1:a006189.
[38] Stefanis L (2012). α-Synuclein in Parkinson's disease. Cold Spring Harb Perspect in Med, 2:a009399.
[39] Madabhushi R, Pan L, Tsai L-H (2014). DNA Damage and Its Links to Neurodegeneration. 83:266-282.
[40] Jordan-Sciutto KL, Murray Fenner BA, Wiley CA, Achim CL (2001). Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia. Experimental neurology, 167:205-214.
[41] Seward ME, Swanson E, Norambuena A, Reimann A, Cochran JN, Li R, et al. (2013). Amyloid-beta signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease. J Cell Sci, 126:1278-1286.
[42] Saad S, Cereghetti G, Feng Y, Picotti P, Peter M, Dechant R (2017). Reversible protein aggregation is a protective mechanism to ensure cell cycle restart after stress. Nat Cell Biol, 19:1202-1213.
[43] Lee C, Zhang H, Baker Amy E, Occhipinti P, Borsuk Mark E, Gladfelter Amy S (2013). Protein Aggregation Behavior Regulates Cyclin Transcript Localization and Cell-Cycle Control. Developmental Cell, 25:572-584.
[44] Arendt T, Bruckner MK, Mosch B, Losche A (2010). Selective cell death of hyperploid neurons in Alzheimer's disease. Am J Pathol, 177:15-20.
[45] Zhang Y-w, Thompson R, Zhang H, Xu H (2011). APP processing in Alzheimer's disease. Molecular Brain, 4:3.
[46] Jin Y, Weisman LS (2015). The vacuole/lysosome is required for cell-cycle progression. eLife, 4:e08160.
[47] Shukla AK, Spurrier J, Kuzina I, Giniger E (2019). Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5. Cell Rep, 26:131-144.e134.
[48] Furuya T, Kim M, Lipinski M, Li J, Kim D, Lu T, et al. (2010). Negative regulation of Vps34 by Cdk mediated phosphorylation. Molecular cell, 38:500-511.
[49] Podmirseg SR, Jakel H, Ranches GD, Kullmann MK, Sohm B, Villunger A, et al. (2016). Caspases uncouple p27(Kip1) from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion. Oncogene, 35:4580-4590.
[50] Yuan J, Yankner BA (2000). Apoptosis in the nervous system. Nature, 407:802-809.
[51] Friedlander RM (2003). Apoptosis and caspases in neurodegenerative diseases. N Engl J Med, 348:1365-1375.
[52] Hashimoto T, Kikkawa U, Kamada S (2011). Contribution of caspase(s) to the cell cycle regulation at mitotic phase. PLoS One, 6:e18449.
[53] Woo SH, Seo S-K, An S, Choe T-B, Hong S-I, Lee Y-H, et al. (2014). Implications of caspase-dependent proteolytic cleavage of cyclin A1 in DNA damage-induced cell death. Biochemical and Biophysical Research Communications, 453:438-442.
[54] Allan LA, Clarke PR (2007). Phosphorylation of Caspase-9 by CDK1/Cyclin B1 Protects Mitotic Cells against Apoptosis. Molecular Cell, 26:301-310.
[55] Bassermann F, Eichner R, Pagano M (2014). The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer. Biochim Biophys Acta, 1843:150-162.
[56] Gong L, Yeh ETH (2006). Characterization of a Family of Nucleolar SUMO-specific Proteases with Preference for SUMO-2 or SUMO-3. 281:15869-15877.
[57] Di Bacco A, Ouyang J, Lee HY, Catic A, Ploegh H, Gill G (2006). The SUMO-specific protease SENP5 is required for cell division. Mol Cell Biol, 26:4489-4498.
[58] Bhutani S, Das A, Maheshwari M, Lakhotia SC, Jana NR (2012). Dysregulation of core components of SCF complex in poly-glutamine disorders. Cell Death Dis, 3:e428.
[59] Fuchsberger T, Lloret A, Vina J (2017). New Functions of APC/C Ubiquitin Ligase in the Nervous System and Its Role in Alzheimer's Disease. Int J Mol Sci, 18.
[60] Husseman JW, Nochlin D, Vincent I (2000). Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol Aging, 21:815-828.
[61] Liu DX, Greene LA (2001). Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res, 305:217-228.
[62] De Bont R, van Larebeke N (2004). Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis, 19:169-185.
[63] Schwartz EI, Smilenov LB, Price MA, Osredkar T, Baker RA, Ghosh S, et al. (2007). Cell Cycle Activation in Postmitotic Neurons is Essential for DNA Repair. Cell Cycle, 6:318-329.
[64] Nouspikel T (2007). DNA repair in differentiated cells: Some new answers to old questions. Neuroscience, 145:1213-1221.
[65] Fishel ML, Vasko MR, Kelley MR (2007). DNA repair in neurons: So if they don’t divide what's to repair? Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 614:24-36.
[66] E. SJ, G. IP, E. MF, J. SP, R. HP, Carol B, et al. (2015). A neuronal DNA damage response is detected at the earliest stages of Alzheimer's neuropathology and correlates with cognitive impairment in the Medical Research Council's Cognitive Function and Ageing Study ageing brain cohort. Neuropathology and Applied Neurobiology, 41:483-496.
[67] Yu H, Harrison FE, Xia F (2018). Altered DNA repair; an early pathogenic pathway in Alzheimer’s disease and obesity. Scientific Reports, 8:5600.
[68] Saha J, Wang S-Y, Davis AJ (2017). Examining DNA Double-Strand Break Repair in a Cell Cycle-Dependent Manner. Methods in enzymology, 591:97-118.
[69] Suberbielle E, Sanchez PE, Kravitz AV, Wang X, Ho K, Eilertson K, et al. (2013). Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β. Nat Neurosci, 16:613.
[70] Suberbielle E, Djukic B, Evans M, Kim DH, Taneja P, Wang X, et al. (2015). DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice. Nature Communications, 6:8897.
[71] Deng C-X (2006). BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic acids research, 34:1416-1426.
[72] Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, et al. (2006). High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nature Genetics, 38:515.
[73] Sanders LH, McCoy J, Hu X, Mastroberardino PG, Dickinson BC, Chang CJ, et al. (2014). Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease. Neurobiology of Disease, 70:214-223.
[74] Sepe S, Milanese C, Gabriels S, Derks Kasper WJ, Payan-Gomez C, van Ijcken Wilfred FJ, et al. (2016). Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson’s Disease. Cell Reports, 15:1866-1875.
[75] Sharma R, Kumar D, Jha NK, Jha SK, Ambasta RK, Kumar P (2017). Re-expression of cell cycle markers in aged neurons and muscles: Whether cells should divide or die? Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1863:324-336.
[76] Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, et al. (1997). Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem, 69:2064-2074.
[77] Qiu H, Lee S, Shang Y, Wang WY, Au KF, Kamiya S, et al. (2014). ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest, 124:981-999.
[78] Farg MA, Konopka A, Soo KY, Ito D, Atkin JD (2017). The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Human Molecular Genetics, 26:2882-2896.
[79] Yamaura M, Mitsushita J, Furuta S, Kiniwa Y, Ashida A, Goto Y, et al. (2009). NADPH Oxidase 4 Contributes to Transformation Phenotype of Melanoma Cells by Regulating G2-M Cell Cycle Progression. Cancer Res, 69:2647.
[80] Zorov DB, Juhaszova M, Sollott SJ (2014). Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release. Physiological Reviews, 94:909-950.
[81] Massaad CA, Klann E (2010). Reactive Oxygen Species in the Regulation of Synaptic Plasticity and Memory. Antioxidants & Redox Signaling, 14:2013-2054.
[82] Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, et al. (2005). AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell, 18:283-293.
[83] Zhang L, Liang P, Zhang R (2015). Impact of Mitochondria-Mediated Apoptosis in U251 Cell Cycle Arrest in G1 Stage and Caspase Activation. Med Sci Monit, 21:3629-3633.
[84] Lee S, Park YY, Kim SH, Nguyen OT, Yoo YS, Chan GK, et al. (2014). Human mitochondrial Fis1 links to cell cycle regulators at G2/M transition. Cell Mol Life Sci, 71:711-725.
[85] Klein JA, Longo-Guess CM, Rossmann MP, Seburn KL, Hurd RE, Frankel WN, et al. (2002). The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature, 419:367.
[86] Lee S, Suk K, Kim IK, Jang IS, Park JW, Johnson VJ, et al. (2008). Signaling pathways of bisphenol A-induced apoptosis in hippocampal neuronal cells: role of calcium-induced reactive oxygen species, mitogen-activated protein kinases, and nuclear factor-kappaB. J Neurosci Res, 86:2932-2942.
[87] Bianco MR, Berbenni M, Amara F, Viggiani S, Fragni M, Galimberti V, et al. (2011). Cross-talk between cell cycle induction and mitochondrial dysfunction during oxidative stress and nerve growth factor withdrawal in differentiated PC12 cells. J Neurosci Res, 89:1302-1315.
[88] Migliore L, Petrozzi L, Lucetti C, Gambaccini G, Bernardini S, Scarpato R, et al. (2002). Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients. Neurology, 58:1809-1815.
[89] Zanon-Moreno V, Marco-Ventura P, Lleo-Perez A, Pons-Vazquez S, Garcia-Medina JJ, Vinuesa-Silva I, et al. (2008). Oxidative stress in primary open-angle glaucoma. J Glaucoma, 17:263-268.
[90] Mancino R, Di Pierro D, Varesi C, Cerulli A, Feraco A, Cedrone C, et al. (2011). Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy. Molecular Vision, 17:1298-1304.
[91] Margrain TH, Boulton M, Marshall J, Sliney DH (2004). Do blue light filters confer protection against age-related macular degeneration? Prog Retin Eye Res, 23:523-531.
[92] Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X (2014). Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim Biophys Acta, 1842:1240-1247.
[93] Chitranshi N, Dheer Y, Gupta V, Abbasi M, Mirzaei M, You Y, et al. (2017). PTPN11 induces endoplasmic stress and apoptosis in SH-SY5Y cells. Neurosci, 364:175-189.
[94] Shen T, You Y, Joseph C, Mirzaei M, Klistorner A, Graham SL, et al. (2018). BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders. Aging Dis, 9:523-536.
[95] Gupta V, Chitranshi N, You Y, Gupta V, Klistorner A, Graham S (2014). Brain derived neurotrophic factor is involved in the regulation of glycogen synthase kinase 3beta (GSK3beta) signalling. Biochem Biophys Res Commun, 454:381-386.
[96] Glotzer M (2001). Animal Cell Cytokinesis. Annu Rev Cell Dev Biol, 17:351-386.
[97] Welsh CF, Roovers K, Villanueva J, Liu Y, Schwartz MA, Assoian RK (2001). Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat Cell Biol, 3:950.
[98] Harrington AW, Kim JY, Yoon SO (2002). Activation of Rac GTPase by p75 Is Necessary for c-<em>jun</em> N-Terminal Kinase-Mediated Apoptosis. J Neurosci, 22:156.
[99] Ridley AJ (2001). Cyclin' Round the Cell with Rac. Developmental Cell, 1:160-161.
[100] Minichiello L, Klein R (1996). TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons. Genes Dev, 10:2849-2858.
[101] Schwartz PM, Borghesani PR, Levy RL, Pomeroy SL, Segal RA (1997). Abnormal cerebellar development and foliation in BDNF-/- mice reveals a role for neurotrophins in CNS patterning. Neuron, 19:269-281.
[102] Boutahar N, Reynaud E, Lassabliere F, Borg J (2010). Brain-derived neurotrophic factor inhibits cell cycle reentry but not endoplasmic reticulum stress in cultured neurons following oxidative or excitotoxic stress. J Neurosci Res, 88:2263-2271.
[103] Xia D, Li W, Zhang L, Qian H, Yao S, Qi X (2014). RNA interference-mediated knockdown of brain-derived neurotrophic factor (BDNF) promotes cell cycle arrest and apoptosis in B-cell lymphoma cells. Neoplasma, 61:523-532.
[104] Mysona BA, Shanab AY, Elshaer SL, El-Remessy AB (2014). Nerve growth factor in diabetic retinopathy: beyond neurons. Expert Rev Ophthalmol, 9:99-107.
[105] Vilar M, Murillo-Carretero M, Mira H, Magnusson K, Besset V, Ibanez CF (2006). Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle. EMBO J, 25:1219-1230.
[106] Ventimiglia R, Mather PE, Jones BE, Lindsay RM (1995). The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci, 7:213-222.
[107] Knusel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, Nikolics K, et al. (1991). Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci U S A, 88:961-965.
[108] Yang Y, Mufson EJ, Herrup K (2003). Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease. The Journal of Neuroscience, 23:2557.
[109] Zhang J, Li H, Zhou T, Zhou J, Herrup K (2012). Cdk5 levels oscillate during the neuronal cell cycle: Cdh1 ubiquitination triggers proteosome-dependent degradation during S-phase. J Biol Chem, 287:25985-25994.
[110] Hamdane M, Buee L (2007). The complex p25/Cdk5 kinase in neurofibrillary degeneration and neuronal death: the missing link to cell cycle. Biotechnol J, 2:967-977.
[111] Klein JA, Ackerman SL (2003). Oxidative stress, cell cycle, and neurodegeneration. Journal of Clinical Investigation, 111:785-793.
[112] Hoozemans JJ, Bruckner MK, Rozemuller AJ, Veerhuis R, Eikelenboom P, Arendt T (2002). Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J Neuropathol Exp Neurol, 61:678-688.
[113] Kim H, Kwon Y-A, Ahn IS, Kim S, Kim S, Jo SA, et al. (2016). Overexpression of Cell Cycle Proteins of Peripheral Lymphocytes in Patients with Alzheimer's Disease. Psychiatry Investigation, 13:127-134.
[114] Di Giovanni S, Movsesyan V, Ahmed F, Cernak I, Schinelli S, Stoica B, et al. (2005). Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci U S A, 102:8333-8338.
[115] Tseng H-C, Zhou Y, Shen Y, Tsai L-H (2002). A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Letters, 523:58-62.
[116] Ding X-L, Husseman J, Tomashevski A, Nochlin D, Jin L-W, Vincent I (2000). The Cell Cycle Cdc25A Tyrosine Phosphatase Is Activated in Degenerating Postmitotic Neurons in Alzheimer's Disease. The American Journal of Pathology, 157:1983-1990.
[117] Park KHJ, Hallows JL, Chakrabarty P, Davies P, Vincent I (2007). Conditional Neuronal Simian Virus 40 T Antigen Expression Induces Alzheimer-Like Tau and Amyloid Pathology in Mice. The Journal of Neuroscience, 27:2969-2978.
[118] Hamley IW (2012). The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. Chem Rev, 112:5147-5192.
[119] Hooper C, Meimaridou E, Tavassoli M, Melino G, Lovestone S, Killick R (2007). p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells. Neuroscience Letters, 418:34-37.
[120] Thakur A, Siedlak SL, James SL, Bonda DJ, Rao A, Webber KM, et al. (2008). Retinoblastoma Protein Phosphorylation at Multiple Sites is Associated with Neurofibrillary Pathology in Alzheimer Disease. International Journal of Clinical and Experimental Pathology, 1:134-146.
[121] Levkovitch-Verbin H, Dardik R, Vander S, Nisgav Y, Kalev-Landoy M, Melamed S (2006). Experimental Glaucoma and Optic Nerve Transection Induce Simultaneous Upregulation of Proapoptotic and Prosurvival Genes. Investigative Ophthalmology & Visual Science, 47:2491-2497.
[122] Johnson EC, Jia L, Cepurna WO, Doser TA, Morrison JC (2007). Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci, 48:3161-3177.
[123] Burdon KP, Macgregor S, Hewitt AW, Sharma S, Chidlow G, Mills RA, et al. (2011). Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet, 43:574-578.
[124] Liu H, Liu W, Zhou X, Long C, Kuang X, Hu J, et al. (2017). Protective effect of lutein on ARPE-19 cells upon H2O2-induced G2/M arrest. Mol Med Rep, 16:2069-2074.
[125] Zhu D, Wu J, Spee C, Ryan SJ, Hinton DR (2009). BMP4 mediates oxidative stress-induced retinal pigment epithelial cell senescence and is overexpressed in age-related macular degeneration. J Biol Chem, 284:9529-9539.
[126] Chen Y, Wang J, Cai J, Sternberg P (2010). Altered mTOR signaling in senescent retinal pigment epithelium. Investigative ophthalmology & visual science, 51:5314-5319.
[127] Ma X, Li H, Wang Y, Wang J, Zheng Q, Hua J, et al. (2017). DAPL1, a susceptibility locus for age-related macular degeneration, acts as a novel suppressor of cell proliferation in the retinal pigment epithelium. Hum Mol Genet, 26:1612-1621.
[128] Kim EJ, Grant GR, Bowman AS, Haider N, Gudiseva HV, Chavali VRM (2018). Complete Transcriptome Profiling of Normal and Age-Related Macular Degeneration Eye Tissues Reveals Dysregulation of Anti-Sense Transcription. Scientific Reports, 8:3040.
[129] Tuo J, Wang Y, Cheng R, Li Y, Chen M, Qiu F, et al. (2015). Wnt signaling in age-related macular degeneration: human macular tissue and mouse model. Journal of Translational Medicine, 13:330.
[130] Podestà F, Romeo G, Liu W-H, Krajewski S, Reed JC, Gerhardinger C, et al. (2000). Bax Is Increased in the Retina of Diabetic Subjects and Is Associated with Pericyte Apoptosis in Vivo and in Vitro. Am J Pathol, 156:1025-1032.
[131] Lopes de Faria JM, Silva KC, Boer PA, Cavalcanti TC, Rosales MA, Ferrari AL, et al. (2008). A decrease in retinal progenitor cells is associated with early features of diabetic retinopathy in a model that combines diabetes and hypertension. Mol Vis, 14:1680-1691.
[132] Gurel Z, Zaro BW, Pratt MR, Sheibani N (2014). Identification of O-GlcNAc modification targets in mouse retinal pericytes: implication of p53 in pathogenesis of diabetic retinopathy. PLoS One, 9:e95561.
[133] Ranganathan S, Bowser R (2003). Alterations in G(1) to S Phase Cell-Cycle Regulators during Amyotrophic Lateral Sclerosis. Am J Pathol, 162:823-835.
[134] Ranganathan S, Bowser R (2010). p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS. The open pathology journal, 4:11-22.
[135] Martin LJ (2000). p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol Dis, 7:613-622.
[136] Nguyen MD, Lariviere RC, Julien JP (2001). Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron, 30:135-147.
[137] Nguyen MD, Boudreau M, Kriz J, Couillard-Després S, Kaplan DR, Julien J-P (2003). Cell Cycle Regulators in the Neuronal Death Pathway of Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase 1. J Neurosci, 23:2131-2140.
[138] Jordan-Sciutto KL, Dorsey R, Chalovich EM, Hammond RR, Achim CL (2003). Expression Patterns of Retinoblastoma Protein in Parkinson Disease. J Neuropathol Exp Neurol, 62:68-74.
[139] Höglinger GU, Breunig JJ, Depboylu C, Rouaux C, Michel PP, Alvarez-Fischer D, et al. (2007). The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc Natl Acad Sci U S A, 104:3585-3590.
[140] Smith PD, Crocker SJ, Jackson-Lewis V, Jordan-Sciutto KL, Hayley S, Mount MP, et al. (2003). Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A, 100:13650-13655.
[141] Mogi M, Kondo T, Mizuno Y, Nagatsu T (2007). p53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain. Neurosci Lett, 414:94-97.
[142] Nair VD, McNaught KS, Gonzalez-Maeso J, Sealfon SC, Olanow CW (2006). p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J Biol Chem, 281:39550-39560.
[143] Sunico CR, Nakamura T, Rockenstein E, Mante M, Adame A, Chan SF, et al. (2013). S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson’s disease. Molecular Neurodegeneration, 8:29.
[144] Castellani RJ, Rolston RK, Smith MA (2010). Alzheimer Disease. Dis Mon, 56:484-546.
[145] Lee H-g, Casadesus G, Zhu X, Castellani RJ, McShea A, Perry G, et al. (2009). Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochem Int 54:84-88.
[146] Currais A, Hortobagyi T, Soriano S (2009). The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease. Aging (Albany NY), 1:363-371.
[147] COPANI A, CONDORELLI F, CARUSO A, VANCHERI C, SALA A, STELLA AMG, et al. (1999). Mitotic signaling by β-amyloid causes neuronal death. FASEB J, 13:2225-2234.
[148] Vincent I, Jicha G, Rosado M, Dickson DW (1997). Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci, 17:3588-3598.
[149] Lee KH, Lee SJ, Lee HJ, Choi GE, Jung YH, Kim DI, et al. (2017). Amyloid beta1-42 (Abeta1-42) Induces the CDK2-Mediated Phosphorylation of Tau through the Activation of the mTORC1 Signaling Pathway While Promoting Neuronal Cell Death. Front Mol Neurosci, 10:229.
[150] Sanphui P, Pramanik SK, Chatterjee N, Moorthi P, Banerji B, Biswas SC (2013). Efficacy of cyclin dependent kinase 4 inhibitors as potent neuroprotective agents against insults relevant to Alzheimer's disease. PLoS One, 8:e78842.
[151] Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai L-H (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature, 402:615.
[152] Li L, Xu ZP, Liu GP, Xu C, Wang ZH, Li XG, et al. (2015). Expression of 1N3R-Tau isoform inhibits cell proliferation by inducing S phase arrest in N2a cells. PLoS One, 10:e0119865.
[153] Hradek AC, Lee HP, Siedlak SL, Torres SL, Jung W, Han AH, et al. (2015). Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer's disease patients. J Alzheimers Dis, 43:57-65.
[154] Bougé A-L, Parmentier M-L (2016). Tau excess impairs mitosis and kinesin-5 function, leading to aneuploidy and cell death. Disease Models & Mechanisms, 9:307-319.
[155] Arendt T (2012). Cell cycle activation and aneuploid neurons in Alzheimer's disease. Mol Neurobiol, 46:125-135.
[156] Mosch B, Morawski M, Mittag A, Lenz D, Tarnok A, Arendt T (2007). Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J Neurosci, 27:6859-6867.
[157] Yang Y, Geldmacher DS, Herrup K (2001). DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease. The Journal of Neuroscience, 21:2661-2668.
[158] Nagy Z, Esiri MM (1997). Apoptosis-Related Protein Expression in the Hippocampus in Alzheimer’s Disease. Neurobiology of Aging, 18:565-571.
[159] Wostyn P, Audenaert K, De Deyn PP (2009). Alzheimer’s disease and glaucoma: Is there a causal relationship? British Journal of Ophthalmology, 93:1557.
[160] Mancino R, Martucci A, Cesareo M, Giannini C, Corasaniti MT, Bagetta G, et al. (2018). Glaucoma and Alzheimer Disease: One Age-Related Neurodegenerative Disease of the Brain. Current Neuropharmacology, 16:971-977.
[161] Kromer R, Serbecic N, Hausner L, Aboul-Enein F, Froelich L, Beutelspacher S (2014). Detection of Retinal Nerve Fiber Layer Defects in Alzheimer’s Disease Using SD-OCT. Frontiers in Psychiatry, 5.
[162] Kirbas S, Turkyilmaz K, Anlar O, Tufekci A, Durmus M (2013). Retinal Nerve Fiber Layer Thickness in Patients With Alzheimer Disease. Journal of Neuro-Ophthalmology, 33:58-61.
[163] Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ (1995). Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci, 36:774-786.
[164] Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME (1997). Tunel-positive ganglion cells in human primary open-angle glaucoma. Archives of Ophthalmology, 115:1031-1035.
[165] Johnson EC, Doser TA, Cepurna WO, Dyck JA, Jia L, Guo Y, et al. (2011). Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest Ophthalmol Vis Sci, 52:504-518.
[166] Pasquale LR, Loomis SJ, Kang JH, Yaspan BL, Abdrabou W, Budenz DL, et al. (2013). CDKN2B-AS1 genotype-glaucoma feature correlations in primary open-angle glaucoma patients from the United States. Am J Ophthalmol, 155:342-353.e345.
[167] Nakano M, Ikeda Y, Tokuda Y, Fuwa M, Omi N, Ueno M, et al. (2012). Common variants in CDKN2B-AS1 associated with optic-nerve vulnerability of glaucoma identified by genome-wide association studies in Japanese. PLoS One, 7:e33389.
[168] Ohno-Matsui K (2011). Parallel findings in age-related macular degeneration and Alzheimer's disease. Prog Retin Eye Res, 30:217-238.
[169] Simó R, Villarroel M, Corraliza L, Hernández C, Garcia-Ramírez M (2010). The Retinal Pigment Epithelium: Something More than a Constituent of the Blood-Retinal Barrier—Implications for the Pathogenesis of Diabetic Retinopathy. 2010:1-15.
[170] Gupta VK, Rajala A, Rajala RV (2012). Insulin receptor regulates photoreceptor CNG channel activity. Am J Physiol Endocrinol Metab, 303:E1363-1372.
[171] Li H, Hua J, Yang J, Pan L, Wang Y, Wang J, et al. (2017). DAPL1, a susceptibility locus for age-related macular degeneration, acts as a novel suppressor of cell proliferation in the retinal pigment epithelium. Human Molecular Genetics, 26:1612-1621.
[172] Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998). Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest, 102:783-791.
[173] Herradón G, Pérez-García C (2014). Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives. British Journal of Pharmacology, 171:837-848.
[174] Zhu X, Bai Y, Yu W, Pan C, Jin E, Song D, et al. (2015). The effects of pleiotrophin in proliferative diabetic retinopathy. PloS one, 10:e0115523-e0115523.
[175] Turner MR, Al-Chalabi A, Chio A, Hardiman O, Kiernan MC, Rohrer JD, et al. (2017). Genetic screening in sporadic ALS and FTD. Journal of Neurology, Neurosurgery & Psychiatry, 88:1042.
[176] Wang X-D, Zhu M-W, Shan D, Wang S-Y, Yin X, Yang Y-Q, et al. (2019). Spy1, a unique cell cycle regulator, alters viability in ALS motor neurons and cell lines in response to mutant SOD1-induced DNA damage. DNA Repair, 74:51-62.
[177] Nakamura M, Bieniek KF, Lin WL, Graff-Radford NR, Murray ME, Castanedes-Casey M, et al. (2015). A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration. Acta Neuropathol, 130:145-157.
[178] Marcuzzo S, Bonanno S, Kapetis D, Barzago C, Cavalcante P, D’Alessandro S, et al. (2015). Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage. 8:5.
[179] Alves Da Costa C, Paitel E, Vincent B, Checler F (2002). Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease. J Biol Chem, 277:50980-50984.
[180] da Costa CA, Ancolio K, Checler F (2000). Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli. J Biol Chem, 275:24065-24069.
[181] Lee SS, Kim YM, Junn E, Lee G, Park KH, Tanaka M, et al. (2003). Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies. Neurobiol Aging, 24:687-696.
[182] Dumitriu A, Pacheco CD, Wilk JB, Strathearn KE, Latourelle JC, Goldwurm S, et al. (2011). Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study. Human Molecular Genetics, 20:1478-1487.
[183] Zhang J, Zeng H, Zhu L, Deng L, Fang X, Deng X, et al. (2016). The Potential Mutation of GAK Gene in the Typical Sporadic Parkinson’s Disease from the Han Population of Chinese Mainland. Molecular Neurobiology, 53:7119-7136.
[184] Ma Z-G, He F, Xu J (2015). Quantitative assessment of the association between GAK rs1564282 C/T polymorphism and the risk of Parkinson’s disease. Journal of Clinical Neuroscience, 22:1077-1080.
[185] Wu J, Stoica BA, Faden AI (2011). Cell Cycle Activation and Spinal Cord Injury. Neurotherapeutics, 8:221-228.
[186] Tominaga T, Shimada R, Okada Y, Kawamata T, Kibayashi K (2019). Senescence-associated-β-galactosidase staining following traumatic brain injury in the mouse cerebrum. PLOS ONE, 14:e0213673.
[187] Kabadi SV, Stoica BA, Byrnes KR, Hanscom M, Loane DJ, Faden AI (2012). Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma. JCBFM, 32:137-149.
[188] Kanungo J, Zheng Y-l, Amin ND, Pant HC (2009). Targeting Cdk5 Activity in Neuronal Degeneration and Regeneration. Cellular and molecular neurobiology, 29:1073-1080.
[189] Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li S-T, Takei K, et al. (2002). Cdk5/p35 Regulates Neurotransmitter Release through Phosphorylation and Downregulation of P/Q-Type Voltage-Dependent Calcium Channel Activity. J Neurosci, 22:2590-2597.
[190] Crews L, Patrick C, Adame A, Rockenstein E, Masliah E (2011). Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease. Cell Death Dis, 2:e120.
[191] Tian DS, Yu ZY, Xie MJ, Bu BT, Witte OW, Wang W (2006). Suppression of astroglial scar formation and enhanced axonal regeneration associated with functional recovery in a spinal cord injury rat model by the cell cycle inhibitor olomoucine. J Neurosci Res, 84:1053-1063.
[192] Yang YM, Gupta SK, Kim KJ, Powers BE, Cerqueira A, Wainger BJ, et al. (2013). A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell stem cell, 12:713-726.
[193] Leclerc S, Garnier M, Hoessel R, Marko D, Bibb JA, Snyder GL, et al. (2001). Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J Biol Chem, 276:251-260.
[194] N. N-R, G. P-Y, M.D. B, A. A, R. I, J.L. D-P, et al. (2009). Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. British Journal of Dermatology, 160:519-526.
[195] Dheer Y, Chitranshi N, Gupta V, Sharma S, Pushpitha K, Abbasi M, et al. (2019). Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice. Exp Neurol, 314:111-125.
[196] Dheer Y, Chitranshi N, Gupta V, Abbasi M, Mirzaei M, You Y, et al. (2018). Bexarotene Modulates Retinoid-X-Receptor Expression and Is Protective Against Neurotoxic Endoplasmic Reticulum Stress Response and Apoptotic Pathway Activation. Mol Neurobiol, 55:9043-9056.
[197] Bain J, McLauchlan H, Elliott M, Cohen P (2003). The specificities of protein kinase inhibitors: an update. Biochemical Journal, 371:199-204.
[198] Blagden S, de Bono J (2005). Drugging cell cycle kinases in cancer therapy. Curr Drug Targets, 6:325-335.
[199] Herrup K, Neve R, Ackerman SL, Copani A (2004). Divide and Die: Cell Cycle Events as Triggers of Nerve Cell Death. The Journal of Neuroscience, 24:9232-9239.
[200] Dörrbaum AR, Kochen L, Langer JD, Schuman EM (2018). Local and global influences on protein turnover in neurons and glia. eLife, 7:e34202.
[201] D’Erchia AM, Gallo A, Manzari C, Raho S, Horner DS, Chiara M, et al. (2017). Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Scientific Reports, 7:10046.
[202] Bartus RT, Weinberg MS, Samulski RJ (2014). Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy. Molecular Therapy, 22:487-497.
[203] Kim SR, Kareva T, Yarygina O, Kholodilov N, Burke RE (2012). AAV Transduction of Dopamine Neurons With Constitutively Active Rheb Protects From Neurodegeneration and Mediates Axon Regrowth. Molecular Therapy, 20:275-286.
[204] Otto T, Sicinski P (2017). Cell cycle proteins as promising targets in cancer therapy. Nature reviews. Cancer, 17:93-115.
[205] Tomita N, Kim JY, Gibbons GH, Zhang L, Kaneda Y, Stahl RA, et al. (2004). Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis. Int J Mol Med, 13:629-636.
[206] Basavarajappa DK, Gupta VK, Dighe R, Rajala A, Rajala RVS (2011). Phosphorylated Grb14 is an endogenous inhibitor of retinal protein tyrosine phosphatase 1B, and light-dependent activation of Src phosphorylates Grb14. Mol Cell Biol, 31:3975-3987.
[207] Gupta VK, Rajala A, Daly RJ, Rajala RV (2010). Growth factor receptor-bound protein 14: a new modulator of photoreceptor-specific cyclic-nucleotide-gated channel. EMBO Rep, 11:861-867.
[208] Chitranshi N, Dheer Y, Mirzaei M, Wu Y, Salekdeh GH, Abbasi M, et al. (2019). Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection. Mol Ther, 27:424-441.
[1] Ya-Fan Zhou, Jing Wang, Man-Fei Deng, Bin Chi, Na Wei, Jian-Guo Chen, Dan Liu, Xiaoping Yin, Youming Lu, Ling-Qiang Zhu. The Peptide-Directed Lysosomal Degradation of CDK5 Exerts Therapeutic Effects against Stroke[J]. Aging and disease, 2019, 10(5): 1140-1145.
[2] Dinesh Upadhya, Maheedhar Kodali, Daniel Gitai, Olagide W Castro, Gabriele Zanirati, Raghavendra Upadhya, Sahithi Attaluri, Eeshika Mitra, Bing Shuai, Bharathi Hattiangady, Ashok K Shetty. A Model of Chronic Temporal Lobe Epilepsy Presenting Constantly Rhythmic and Robust Spontaneous Seizures, Co-morbidities and Hippocampal Neuropathology[J]. Aging and disease, 2019, 10(5): 915-936.
[3] Kyoungjoo Cho. Emerging Roles of Complement Protein C1q in Neurodegeneration[J]. Aging and disease, 2019, 10(3): 652-663.
[4] Saumyendra N. Sarkar, Ashley E. Russell, Elizabeth B. Engler-Chiurazzi, Keyana N. Porter, James W. Simpkins. MicroRNAs and the Genetic Nexus of Brain Aging, Neuroinflammation, Neurodegeneration, and Brain Trauma[J]. Aging and disease, 2019, 10(2): 329-352.
[5] Ana C. Calvo, Gabriela Atencia Cibreiro, Paz Torre Merino, Juan F. Roy, Adrián Galiana, Alexandra Juárez Rufián, Juan M. Cano, Miguel A. Martín, Laura Moreno, Pilar Larrodé, Pilar Cordero Vázquez, Lucía Galán, Jesús Mora, José L. Muñoz-Blanco, María J. Muñoz, Pilar Zaragoza, Elena Pegoraro, Gianni Sorarù, Marina Mora, Christian Lunetta, Silvana Penco, Claudia Tarlarini, Jesús Esteban, Rosario Osta, Alberto García Redondo. Collagen XIX Alpha 1 Improves Prognosis in Amyotrophic Lateral Sclerosis[J]. Aging and disease, 2019, 10(2): 278-292.
[6] Jianji Xu,Yunjin Zang,Dongjie Liu,Tongwang Yang,Jieling Wang,Yanjun Wang,Xiaoni Liu,Dexi Chen. DRAM is Involved in Hypoxia/Ischemia-Induced Autophagic Apoptosis in Hepatocytes[J]. Aging and disease, 2019, 10(1): 82-93.
[7] Antonina Luca, Carmela Calandra, Maria Luca. Molecular Bases of Alzheimer’s Disease and Neurodegeneration: The Role of Neuroglia[J]. Aging and disease, 2018, 9(6): 1134-1152.
[8] Yang Yao-Chih, Tsai Cheng-Yen, Chen Chien-Lin, Kuo Chia-Hua, Hou Chien-Wen, Cheng Shi-Yann, Aneja Ritu, Huang Chih-Yang, Kuo Wei-Wen. Pkcδ Activation is Involved in ROS-Mediated Mitochondrial Dysfunction and Apoptosis in Cardiomyocytes Exposed to Advanced Glycation End Products (Ages)[J]. Aging and disease, 2018, 9(4): 647-663.
[9] Zhang Jun, Liu Kaiyin, Elmadhoun Omar, Ji Xunming, Duan Yunxia, Shi Jingfei, He Xiaoduo, Liu Xiangrong, Wu Di, Che Ruiwen, Geng Xiaokun, Ding Yuchuan. Synergistically Induced Hypothermia and Enhanced Neuroprotection by Pharmacological and Physical Approaches in Stroke[J]. Aging and disease, 2018, 9(4): 578-589.
[10] Liu Xiangrong, Wen Shaohong, Zhao Shunying, Yan Feng, Zhao Shangfeng, Wu Di, Ji Xunming. Mild Therapeutic Hypothermia Protects the Brain from Ischemia/Reperfusion Injury through Upregulation of iASPP[J]. Aging and disease, 2018, 9(3): 401-411.
[11] Li Guangwen, Ma Qingfeng, Wang Rongliang, Fan Zhibin, Tao Zhen, Liu Ping, Zhao Haiping, Luo Yumin. Diagnostic and Immunosuppressive Potential of Elevated Mir-424 Levels in Circulating Immune Cells of Ischemic Stroke Patients[J]. Aging and disease, 2018, 9(2): 172-781.
[12] Liu Jie, Tang Ling-yun, Wang Yan-gui, Lu Shun-yuan, Zhang En-ning, Wang Zhu-gang, Zhang Hong-xin. Identification of MAVS as a Novel Risk Factor for the Development of Osteoarthritis[J]. Aging and disease, 2018, 9(1): 40-50.
[13] Liang Wei, Huang Xiaobo, Chen Wenqiang. The Effects of Baicalin and Baicalein on Cerebral Ischemia: A Review[J]. Aging and disease, 2017, 8(6): 850-867.
[14] Wang Jue, Cao Bin, Zhao Haiping, Feng Juan. Emerging Roles of Ganoderma Lucidum in Anti-Aging[J]. Aging and disease, 2017, 8(6): 691-707.
[15] Gao Yanjie, Wei Yifo, Wang Yuqing, Gao Fang, Chen Zhigang. Lycium Barbarum: A Traditional Chinese Herb and A Promising Anti-Aging Agent[J]. Aging and disease, 2017, 8(6): 778-791.
Viewed
Full text


Abstract

Cited

  Shared   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd